EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) MUTATION ANALYSIS (EXON 18, 19, 20, 21) (SDL11115)
This test detects EGFR mutations in tumor tissue for lung cancer. Positive results guide TKI therapy like osimertinib, optimizing treatment for non-small cell lung carcinoma.